Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV

Summary: Patients with HIV exhibit platelet activation and increased risk of cardiovascular disease, the prevention of which is not fully known. Fifty-five HIV-positive patients were randomized to clopidogrel, aspirin, or no-treatment for 14 days, and the platelet phenotype and ability to induce end...

Full description

Bibliographic Details
Main Authors: Emanuela Marcantoni, PhD, Michael S. Garshick, MD, MS, Tamar Schwartz, BA, Nicole Ratnapala, MS, Matthew Cambria, BA, Rebecca Dann, MS, Meagan O’Brien, MD, Adriana Heguy, PhD, Jeffrey S. Berger, MD, MS
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:JACC: Basic to Translational Science
Subjects:
aspirin
clopidogrel
endothelium
HIV
platelets
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X22002200

Similar Items

Similar Items